TCL1 expression patterns in Waldenström macroglobulinemia.

about

Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia.

P2860

Q37490002-5BB10C38-6DC4-4AD7-9AD4-E72678EB411C

P2860

TCL1 expression patterns in Waldenström macroglobulinemia.

Item

http://www.wikidata.org/entity/Q41192923

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

TCL1 expression patterns in Waldenström macroglobulinemia.

@en

type

Item

label

TCL1 expression patterns in Waldenström macroglobulinemia.

@en

prefLabel

TCL1 expression patterns in Waldenström macroglobulinemia.

@en

P1476

TCL1 expression patterns in Waldenström macroglobulinemia.

@en

P2093

Albane Ledoux-Pilon

http://www.w3.org/2001/XMLSchema#string

Aurélie Ravinet

http://www.w3.org/2001/XMLSchema#string

Frédéric Charlotte

http://www.w3.org/2001/XMLSchema#string

Laura Montrieul

http://www.w3.org/2001/XMLSchema#string

Olivier Tournilhac

http://www.w3.org/2001/XMLSchema#string

Pierre J Déchelotte

http://www.w3.org/2001/XMLSchema#string

Pierre Morel

http://www.w3.org/2001/XMLSchema#string

Richard Lemal

http://www.w3.org/2001/XMLSchema#string

Romain Guièze

http://www.w3.org/2001/XMLSchema#string

Sandrine Bard-Sorel

http://www.w3.org/2001/XMLSchema#string

P2860

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

The protooncogene TCL1 is an Akt kinase coactivator

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

Targeting NF-kappaB in Waldenstrom macroglobulinemia

Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis

Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.

Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity

P2888

modpathol.2015.122

P304

83-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2015.122

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030499399

http://www.w3.org/2001/XMLSchema#string

P698

26493619

http://www.w3.org/2001/XMLSchema#string

TCL1 expression patterns in Waldenström macroglobulinemia.

about

P2860

P2860

TCL1 expression patterns in Waldenström macroglobulinemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698